Clin2
NCT04838392Possibly a fitNot yet recruiting

Testing an arm glucose monitor for diabetes blood sugar control

Diabetes MellitusType 1 DiabetesType 2 Diabetes

Part of Hormones & metabolism, Immune system & allergy clinical trials.

This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have type 1 or type 2 diabetes
  • You can attend all study visits and follow the study team’s instructions
  • You’re willing to wear one glucose sensor on each upper arm at the same time
  • You’re willing to have your glucose levels adjusted during each clinic visit
  • You can speak, read, and write English and can sign consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07386340Recruiting
Testing a new continuous glucose monitor with flash readings

This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.

Escondido, California
NCT06764069Recruiting
New sensor for continuous blood sugar monitoring

This study tests a new glucose sensor placed inside a blood vessel to see how well it measures blood sugar. If you have diabetes and use intensive insulin therapy, this could be a way to help improve monitoring.

São Paulo, Brazil
NCT07122180Enrolling by invitation
14-day study of a new continuous glucose monitor for diabetes

This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.

Riga, Riga
NCT07308925Not yet recruiting
Real-time vs intermittent glucose monitoring in type 2 diabetes

This trial compares two types of continuous glucose monitors to see which works better for people with type 2 diabetes who use insulin. You will wear a sensor that tracks your blood sugar levels continuously or at set times, and the study will help find the best way to manage your diabetes.

Bogotá
NCT05633628Recruiting
Wear a continuous glucose monitor with type 2 diabetes

This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.

Stockholm
NCT07092761Recruiting
Testing a new continuous glucose monitor

This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.

Luoyang, Henan

Hear when a new Diabetes Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.